Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Last chance to register for the International Pandemic Sciences Conference 2024

Mark your calendars for the International Pandemic Sciences Conference 2024, coming to Oxford and streaming online on 1 and 2 July 2024.

Pandemic computer simulations to guide future vaccine trials

PSI scientists are launching a new computer simulations project to model vaccine clinical trial designs and strengthen global response to pandemic threats.

Professor Teresa Lambe elected to Fellowship of Academy of Medical Sciences

Professor Teresa Lambe OBE, Calleva Head of Immunology at the Oxford Vaccine Group, and Principal Investigator at the Pandemic Sciences Institute, has been elected a Fellow of the Academy of Medical Sciences, one of the most prestigious awards in the field.

PSI Director Professor Sir Peter Horby elected Fellow of Royal Society

Professor Sir Peter Horby has been elected as a Fellow of the Royal Society, joining a cohort of the world’s most eminent scientists, engineers and technologists who have made substantial contributions to the advancement of science.

Late-breaking abstracts – submissions now open

Whether new research or emerging insights on current outbreaks such as mpox and H5N1, the International Pandemic Sciences Conference 2024 is inviting abstracts for presentation in our late-breaking parallel session.

Pandemic policy roadmap for funders commended in prestigious Vice-Chancellor’s Awards

A team from PSI’s Policy and Practice Research Group are finalists in the University of Oxford’s Vice-Chancellor Awards for outstanding research engagement.

Science Museum’s Injecting Hope exhibition enters final week

The exhibition, which features stories and items from University of Oxford researchers, explores the worldwide effort to develop vaccines against COVID-19 and shares the inspiring stories of scientists collaborating around the globe to save lives. Closing on 12 May, the exhibition has welcomed millions of visitors in London, India and China.

New ethical framework for coercive antimicrobial stewardship policies

Published in the journal Public Health Ethics, the research introduces an ethical framework for assessing the use of coercive antimicrobial stewardship policies to address the ‘silent pandemic’ of antimicrobial resistance.

Researchers enrol record number of patients for landmark plague trial

A randomised controlled trial to evaluate the efficacy and safety of treatments for bubonic plague has enrolled over 220 patients in Madagascar, marking a critical milestone in evidence generation for plague treatments.

Oxford hosts Belgian vaccine experts

Researchers from Oxford Vaccine Group and the Pandemic Sciences Institute welcomed a delegation of vaccine researchers from Belgium to further UK-Belgian collaboration on vaccine development and manufacture.

Speaker line-up announced for the International Pandemic Sciences Conference 2024

Meet the presenters, panellists and chairs for the International Pandemic Sciences Conference 2024, set to take place on 1–2 July 2024 in Oxford and online.

New Pandemic PACT research programme launched

The Pandemic Sciences Institute, in collaboration with the global coalition of health research funders GloPID-R and UKCDR, has launched a new research programme including an interactive platform to track and analyse over $7 billion in global pandemic research funding.

Study reveals high number of persistent COVID-19 infections in the general population

A new study – led by researchers at PSI – has found that a high proportion of SARS-CoV-2 infections in the general population lead to persistent infections lasting a month or more. The findings have been published today in the journal Nature.

Abstract submission deadline extended: International Pandemic Sciences Conference 2024

The deadline for abstract submissions and bursary applications for the International Pandemic Sciences Conference 2024 – Collaboration Beyond Boundaries has been extended to Monday 26 February 2024.

Students explore 'wicked problem' of pandemics

Students on the MSc International Health and Tropical Medicine programme discussed pandemics, during a day exploring some of the major challenges in global health, hosted by PSI's Dr Alice Norton.

New teaching collaboration with Brazilian universities

The University of Oxford has entered into an agreement with three Brazilian universities, to contribute to the delivery of an undergraduate course in ‘Translational Science’, starting in 2024. The course will teach the full journey of a product ‘from bench to bedside’ as part of any science degree to prepare the next generation of researchers for the translation of their laboratory discoveries into patient care and prevention.

FCDO Minister meets with University of Oxford’s vaccine researchers

The University of Oxford this week welcomed the Rt Hon Andrew Mitchell MP, Minister for Development and Africa, to the laboratories and clinics of several of its vaccine development groups.

Registration open for International Pandemic Sciences Conference 2024

PSI set to host international scientific conference in Oxford and online this July, to foster global research collaboration and prepare world for future pandemics.

Public health vision led by researchers from Oxford and Bangladesh aims to tackle Nipah virus

In a new paper published in The Lancet Infectious Diseases, researchers based in Bangladesh, Oxford and Geneva call for a comprehensive public health framework to counter Nipah virus and other neglected infectious diseases with pandemic potential.

Vaccine trial for deadly Nipah virus launched

Oxford-led UK trial is first step to developing a vaccine against Nipah virus – a devastating disease mostly found in South-East Asia.

Load More